Treatment of chronic delta hepatitis with peglylated interferon.

Trial Profile

Treatment of chronic delta hepatitis with peglylated interferon.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 May 2014

At a glance

  • Drugs Peginterferon alfa-2a (Primary)
  • Indications Hepatitis D
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jun 2012 Planned end date changed from 1 May 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
    • 21 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 18 May 2010 Planned end date changed from 1 May 2010 to 1 May 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top